ARS Pharmaceuticals Inc.
SPRY | NASDAQ
$4.50
+$0.15 (+3.45%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -215.43M | -197.98M | -171.3M | -80.04M | -48.02M | -15.65M | 8M | -49.1M | -44.84M | -49.7M | -54.37M | -61.63M | -53.34M | -42.39M | -34.68M | -43.71M | -59.79M | -77.86M | -89.48M | -66.02M | -43.36M | -25.33M |
Depreciation & Amortization | 1.62M | 1.48M | -594K | -565K | -2.9M | -3.16M | -1.47M | 62K | 62K | 64K | 73K | 75K | 61K | 529K | 559K | 975K | 1.51M | 1.51M | 1.93M | 1.5M | 958K | 869K |
Stock-Based Compensation | 31.24M | 24.22M | 22.1M | 20.62M | 18.52M | 16.52M | 14.53M | 12.55M | 11.57M | 8.2M | 4.89M | 7.37M | 5.22M | 5.22M | 5.49M | 724K | 264K | 264K | n/a | n/a | n/a | n/a |
Other Working Capital | -2.18M | 4.73M | 306K | -9.37M | -10.89M | -14.36M | -8.46M | -813K | -396K | -977K | -4.55M | -3.77M | -3.63M | -4.43M | -1.73M | -3.67M | -5.37M | -4.13M | -4.43M | -1.39M | 263K | -864K |
Other Non-Cash Items | -1.07M | -1.81M | -1.07M | -2.17M | 3.21M | 609K | -1.37M | 8.06M | 3.98M | 6.23M | 8.65M | -10.84M | -8.57M | -9M | -9.44M | 5.78M | 10.09M | 14.9M | 19.19M | 14.04M | 9.02M | 4.42M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.18M | -11.18M | -11.18M | -11.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -12.77M | -988K | -20M | -23.22M | -23.61M | -18.8M | -6.15M | -6.24M | -3.74M | -7.17M | -7.33M | 2.66M | 1.35M | 58K | -2M | -4.65M | -6.4M | -302K | 1.6M | 5.03M | 7.05M | 2.4M |
Operating Cash Flow | -196.41M | -175.07M | -170.87M | -85.38M | -52.8M | -20.48M | 13.55M | -45.86M | -44.16M | -53.55M | -59.27M | -62.36M | -55.28M | -45.58M | -40.08M | -40.89M | -54.32M | -61.48M | -66.76M | -45.46M | -26.34M | -17.64M |
Capital Expenditures | -197K | -248K | -339K | -641K | -584K | -571K | -563K | -170K | -73K | -65K | -175K | -392K | -379K | -371K | -199K | -623K | -680K | -1.36M | -1.37M | -822K | -735K | -40K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25.95M | 20.65M | 20.65M | 20.65M | 46.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -210.93M | -222.4M | -242.03M | -356.61M | -270.72M | -326.95M | -356.04M | -226.63M | -291.69M | -204.08M | -272.01M | -237.95M | -131.35M | -131.35M | n/a | -25.14M | -65.11M | -65.11M | -65.11M | -39.97M | n/a | n/a |
Sales Maturities Of Investments | 267.48M | 286M | 307M | 299M | 271.5M | 266.5M | 258M | 251M | 250M | 220M | 185M | 125M | 65M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -7.86M | -7.86M | -7.86M | -10.86M | -7.5M | -7.5M | -7.5M | 23.45M | -20.65M | -20.65M | -20.65M | -46.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 48.5M | 55.5M | 56.77M | -69.11M | -7.31M | -68.52M | -106.1M | 21.7M | -41.76M | 15.85M | -87.18M | -113.35M | -66.73M | -111.72M | -199K | -25.76M | -65.79M | -66.46M | -66.48M | -40.79M | -735K | -40K |
Debt Repayment | 96.26M | 96.26M | 96.26M | 96.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.95M | -6.86M | -7.77M | -8.68M | -2.73M | -1.82M | -1.4M | -846K | -846K | -846K | -467K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.17M | 2.76M | 2.66M | 71.96M | 69.38M | 69.38M | 69.38M | n/a | n/a | n/a | n/a | 199.77M | 199.13M | 199.13M | 199.13M | -647K | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 104.53M | 104.03M | 104.6M | 174.38M | 75.02M | 72.87M | 72.4M | 3.29M | 3.53M | 5.84M | 6.9M | 198.91M | 196.44M | 192.96M | 190.73M | -2.81M | -1.11M | -166K | 614K | 339K | 191K | 11.81M |
Net Cash Flow | -43.38M | -15.54M | -9.5M | 19.9M | 14.91M | -16.14M | -20.15M | -20.88M | -82.39M | -31.86M | -139.55M | 23.21M | 74.43M | 27.97M | 142.78M | -77.04M | -128.8M | -128.01M | -132.52M | -85.91M | -26.88M | -12.36M |
Free Cash Flow | -196.6M | -175.32M | -171.21M | -86.02M | -53.38M | -21.06M | 12.99M | -46.03M | -44.23M | -53.61M | -59.44M | -62.75M | -55.66M | -45.95M | -40.28M | -41.51M | -55M | -62.84M | -68.13M | -46.28M | -27.07M | -17.68M |
Adj. Free Cash Flow | -227.85M | -199.54M | -193.3M | -106.64M | -71.9M | -37.57M | -1.55M | -58.58M | -55.8M | -61.81M | -64.33M | -70.12M | -60.88M | -51.18M | -45.76M | -42.23M | -55.27M | -63.11M | -68.13M | -46.28M | -27.07M | -17.68M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -83K | 8K | -35K | -65K | -175K | -392K | -379K | -371K | -199K | -257.84K | -314.84K | -292.84K | -271.84K | -92K | -38K | n/a |
Growth CapEx | -197K | -248K | -339K | -641K | -584K | -571K | -480K | -178K | -38K | n/a | n/a | n/a | n/a | n/a | n/a | -365.16K | -365.16K | -1.07M | -1.1M | -735K | -735K | n/a |
Owner Earnings | -196.41M | -175.07M | -170.87M | -85.38M | -52.8M | -20.48M | 13.47M | -45.85M | -44.19M | -53.61M | -59.44M | -62.75M | -55.66M | -45.95M | -40.28M | -41.14M | -54.64M | -61.78M | -67.03M | -50.99M | -39.45M | n/a |
Add to Watchlist
Select watchlists to add or remove SPRY